South Korea’s president faces calls to resign

Unlock Editor’s Digest for free Roula Khalaf, editor of the FT, picks her favorite stories in this weekly newsletter. South Korean President Yoon Suk Yeol faced mounting calls for his impeachment on Wednesday after his failed attempt to impose martial law sparked the country’s worst constitutional crisis in decades. Opposition lawmakers called on him to…

Read More

Australia calls for more choice for internet users amid Google dominance, genAI By Reuters

(Reuters) – Australia’s competition watchdog said there was a need to review efforts to provide more choice for Internet users, citing Google’s (NASDAQ: ) dominant search engine market share and the failure of its rivals to capitalize on the boom in artificial intelligence. A report by the Australian Competition and Consumer Commission said that while…

Read More

VAPORESSO a pioneer in eco-innovation for a sustainable future of vaping Investing.com

SHENZHEN, China, December 3, 2024 /PRNewswire/ — This December VAPORESSO, a prominent name in the vaping industry, continues its unwavering commitment to sustainability by announcing the launch of its Global Environmental Empowerment Initiative “CLEAN POWER FOR ALL”. This initiative encompasses a range of impactful activities online and offline. Through the development of environmentally friendly products,…

Read More

Australian dollar falls to 4-month low as soft GDP prompts rate cut bets By Investing.com

Investing.com– The Australian dollar fell sharply on Wednesday after weaker-than-expected gross domestic product data fueled increased bets that the Reserve Bank will cut interest rates earlier in 2025. The pair slipped 1.1% to $0.6411 by 22:30 ET (0330 GMT). The third quarter rose 0.8% year-on-year, missing expectations of 1.1% and slowing from the 1% reported…

Read More

Revolution Medicines Announces Pricing of $750.0 Million Raised Public Offering of Common Stock and Pre-Funded Warrants from Investing.com

REDWOOD CITY, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-dependent cancers, today announced pricing for 14,130,436 shares of its common stock at a public offering price of $46.00 per share, previously taking discounts and commissions, and, instead of ordinary shares,…

Read More

4 ‘fatal flaws’ in Tesla’s bid to award Elon Musk $100 billion, according to judge who suspended his salary

A judge this week halted a comprehensive effort to grant Tesla CEO Elon Musk a pay package now estimated at $100 billion. On 101 pages opinionChancellor of the Delaware Court Kathleen McCormick refused to overturn the previous decision to terminate Musk’s salary. In essence, she wrote, the defense arguments representing Tesla and some of the…

Read More